News
23h
AstraZeneca Plc (NASDAQ:AZN) released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) Phase 3 program. The trial showed that anselamimab, a light chain depleter ...
(Yicai) July 17 -- Sino Biopharmaceutical said the Chinese drugmaker plans to invest no more than USD951 million to fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback